Vignesh Rajah, SVP & CMO at Y-mAbs Therapeutics, Inc. (YMAB), bought 1,374 shares at $29.95 ($41K) on 2021-08-12, disclosed to the SEC on 2021-08-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| YMAB | BUY | 2020-12-04 | $146K | — | Filing → |